Pathogenesis of Hepatic Injury with HCV/HIV Coinfection
HCV/HIV 合并感染肝损伤的发病机制
基本信息
- 批准号:6450551
- 负责人:
- 金额:$ 34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-30 至 2006-08-31
- 项目状态:已结题
- 来源:
- 关键词:CD95 molecule HIV envelope protein gp120 HIV infections apoptosis comorbidity hepatitis C hepatitis C virus human immunodeficiency virus 1 human tissue inflammation interleukin 8 liver cells liver disorder mitogen activated protein kinase molecular pathology protein protein interaction transcription factor virus envelope virus protein virus virus interaction
项目摘要
DESCRIPTION: (provided by applicant) The primary objective of this proposal is
to examine how the hepatitis C virus (HCV) and the human immunodeficiency virus
(HIV) envelope proteins may act collaboratively to trigger signaling events
that contribute to hepatocyte inflammation and apoptosis. Coinfection with HIV
and HCV confers a poor prognosis, with progressive hepatic dysfunction that
often results in cirrhosis and death. Both intravenous drug users and
hemophiliacs have a high incidence of coinfection and face this grim outcome.
Why do coinfected hosts have such high rates of progressive liver disease? The
pathogenesis of HCV-related hepatitis is believed to be due, in part, to
immune-mediated inflammation as well as the effects of direct infection of
hepatocytes. Our preliminary data suggest a novel third potential mechanism for
hepatic inflammation and apoptosis. We observed in both HepG2 cells and primary
hepatocytes that treatment with the HCV envelope protein E2, in conjunction
with HIV gpl20, induced the inflammatory chemokine interleukin-8 (IL-8) and
triggered apoptosis. These functional outcomes occurred at nanomolar
concentrations of E2 and gp 120 that correspond to the Kd's for the cognate
ligands binding to their respective receptors, CDS1 and CXCR4, and were
associated with activation of specific signaling molecules, including the Src
family Lyn kinase, RAFTK/Pyk2, Erkl/2 and p38 MAP kinases, and Fas-ligand.
These data indicate that proinflammatory and apoptotic events may occur due to
dual exposure to HCV and HIV envelope proteins via an "innocent bystander"
mechanism. This proposal seeks to characterize the molecular mechanisms of IL-8
induction and the program of apoptosis caused by HCV E2 and HIV gpl20. A
focused experimental approach is presented to delineate signaling events that
originate at specific cell surface receptors, are transduced through
intermediate signaling molecules, and converge on transcriptional activators of
the MAP kinase family. Elucidating how these HCV and HIV envelope proteins may
interact with hepatocytes could not only further our understanding of the
pathogenesis of disease in coinfected hosts but also lead to targeted
therapeutic strategies to improve the currently poor prognosis of such
individuals.
描述:(由申请人提供)该提案的主要目标是
检查丙型肝炎病毒 (HCV) 和人类免疫缺陷病毒如何
(HIV) 包膜蛋白可能协同作用以触发信号事件
有助于肝细胞炎症和细胞凋亡。合并感染艾滋病毒
HCV 预后不良,伴有进行性肝功能障碍,
常常导致肝硬化和死亡。静脉注射吸毒者和
血友病患者合并感染的发生率很高,因此面临着严峻的后果。
为什么合并感染的宿主进展性肝病的发生率如此之高?这
HCV 相关性肝炎的发病机制被认为部分归因于
免疫介导的炎症以及直接感染的影响
肝细胞。我们的初步数据表明了一种新颖的第三种潜在机制
肝脏炎症和细胞凋亡。我们在 HepG2 细胞和原代细胞中观察到
用 HCV 包膜蛋白 E2 联合处理的肝细胞
与 HIV gpl20 一起,诱导炎症趋化因子白细胞介素 8 (IL-8) 和
引发细胞凋亡。这些功能结果发生在纳摩尔
E2 和 gp 120 的浓度对应于同源的 Kd
配体与其各自的受体 CDS1 和 CXCR4 结合,并且
与特定信号分子的激活相关,包括 Src
Lyn 激酶家族、RAFTK/Pyk2、Erk1/2 和 p38 MAP 激酶以及 Fas 配体。
这些数据表明,促炎和凋亡事件可能是由于以下原因发生的:
通过“无辜旁观者”双重暴露于 HCV 和 HIV 包膜蛋白
机制。该提案旨在描述 IL-8 的分子机制
HCV E2和HIV gpl20引起的细胞凋亡的诱导和程序。一个
提出了集中的实验方法来描述信号事件
起源于特定的细胞表面受体,通过转导
中间信号分子,并集中在转录激活子上
MAP 激酶家族。阐明这些 HCV 和 HIV 包膜蛋白如何可能
与肝细胞的相互作用不仅可以加深我们对肝细胞的理解
共同感染宿主疾病的发病机制,但也导致有针对性的
改善此类疾病目前不良预后的治疗策略
个人。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEROME E GROOPMAN其他文献
JEROME E GROOPMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEROME E GROOPMAN', 18)}}的其他基金
Cocaine induces production of infectious large extracellular vesicles (lEV) and regulates neuro-inflammation
可卡因诱导产生传染性大细胞外囊泡 (lEV) 并调节神经炎症
- 批准号:
10208847 - 财政年份:2020
- 资助金额:
$ 34万 - 项目类别:
Novel Mechanisms of Disarming Anti-HIV Host Defenses by Methamphetamine
甲基苯丙胺解除抗艾滋病毒宿主防御的新机制
- 批准号:
8900552 - 财政年份:2015
- 资助金额:
$ 34万 - 项目类别:
Novel Mechanisms of Disarming Anti-HIV Host Defenses by Methamphetamine
甲基苯丙胺解除抗艾滋病毒宿主防御的新机制
- 批准号:
9113553 - 财政年份:2015
- 资助金额:
$ 34万 - 项目类别:
Novel Strategies to Antagonize Cocaine-Enhanced HIV Pathobiology
对抗可卡因增强的艾滋病毒病理学的新策略
- 批准号:
8598406 - 财政年份:2013
- 资助金额:
$ 34万 - 项目类别:
Novel Strategies to Antagonize Cocaine-Enhanced HIV Pathobiology
对抗可卡因增强的艾滋病毒病理学的新策略
- 批准号:
8669962 - 财政年份:2013
- 资助金额:
$ 34万 - 项目类别:
Inhibition of HIV at the Immune Synapse Utilizing Novel Ligands and Receptors
利用新型配体和受体抑制免疫突触中的 HIV
- 批准号:
7932131 - 财政年份:2008
- 资助金额:
$ 34万 - 项目类别:
Inhibition of HIV at the Immune Synapse Utilizing Novel Ligands and Receptors
利用新型配体和受体抑制免疫突触中的 HIV
- 批准号:
7683286 - 财政年份:2008
- 资助金额:
$ 34万 - 项目类别:
Inhibition of HIV at the Immune Synapse Utilizing Novel Ligands and Receptors
利用新型配体和受体抑制免疫突触中的 HIV
- 批准号:
8116997 - 财政年份:2008
- 资助金额:
$ 34万 - 项目类别:
Inhibition of HIV at the Immune Synapse Utilizing Novel Ligands and Receptors
利用新型配体和受体抑制免疫突触中的 HIV
- 批准号:
8306236 - 财政年份:2008
- 资助金额:
$ 34万 - 项目类别:
Pathogenesis of Hepatic Injury with HCV/HIV Coinfection
HCV/HIV 合并感染肝损伤的发病机制
- 批准号:
6657216 - 财政年份:2001
- 资助金额:
$ 34万 - 项目类别:
相似国自然基金
蛋白酶抑制剂通过自噬通路对HIV-1包膜蛋白gp120神经毒性的影响及机制研究
- 批准号:81571178
- 批准年份:2015
- 资助金额:57.0 万元
- 项目类别:面上项目
HIV包膜蛋白gp120降解多肽形成淀粉样纤维结构促进HIV感染的研究
- 批准号:31370781
- 批准年份:2013
- 资助金额:75.0 万元
- 项目类别:面上项目
包膜蛋白gp120在HIV-1侵犯血-视网膜屏障中的机制研究
- 批准号:30471851
- 批准年份:2004
- 资助金额:21.0 万元
- 项目类别:面上项目
相似海外基金
Pathogenesis of Hepatic Injury with HCV/HIV Coinfection
HCV/HIV 合并感染肝损伤的发病机制
- 批准号:
6657216 - 财政年份:2001
- 资助金额:
$ 34万 - 项目类别:
Pathogenesis of Hepatic Injury with HCV/HIV Coinfection
HCV/HIV 合并感染肝损伤的发病机制
- 批准号:
6946364 - 财政年份:2001
- 资助金额:
$ 34万 - 项目类别:
Pathogenesis of Hepatic Injury with HCV/HIV Coinfection
HCV/HIV 合并感染肝损伤的发病机制
- 批准号:
6523560 - 财政年份:2001
- 资助金额:
$ 34万 - 项目类别:
Pathogenesis of Hepatic Injury with HCV/HIV Coinfection
HCV/HIV 合并感染肝损伤的发病机制
- 批准号:
6653015 - 财政年份:2001
- 资助金额:
$ 34万 - 项目类别:
Pathogenesis of Hepatic Injury with HCV/HIV Coinfection
HCV/HIV 合并感染肝损伤的发病机制
- 批准号:
6797950 - 财政年份:2001
- 资助金额:
$ 34万 - 项目类别: